Posted by Michael Wonder on 16 May 2019
US drug pricing is in need of an overhaul
16 May 2019 - The structure of the market suits everyone involved, except for ill Americans.
President Donald Trump’s push to bring down drug prices in the US is long overdue. It is also one of the few areas where Mr Trump may be able to forge a bipartisan consensus with Democrats. The current Byzantine system penalises Americans for falling sick. A radical overhaul is needed.
Mr Trump made tackling the costs of pharmaceuticals a campaign promise in 2016. Drugmakers price the most frequently administered treatment about 1.8 times higher in the US than in other developed countries.
